GS
This company offers a genetic test, the Genome Shield iPGX Test, that analyzes a patient's DNA to predict their response to specific medications. The test helps physicians and pharmacists determine the optimal drug and dosage for individual patients, reducing adverse reactions and improving drug efficacy.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company offers a genetic test, the Genome Shield iPGX Test, that analyzes a patient's DNA to predict their response to specific medications. The test helps physicians and pharmacists determine the optimal drug and dosage for individual patients, reducing adverse reactions and improving drug efficacy.